findmyKOL
Clinical trialNCT01612000CompletedPhase 1/PHASE2Interventional

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults

SponsorProtein Sciences CorporationEnrollment341Influenza
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Meridian Clinical Research

    Omaha, Nebraska, United States

  • University of Rochester Center for Vaccine Studies

    Rochester, New York, United States

  • Benchmark Reseach

    Austin, Texas, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • Jean Brown Research

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2012
Primary completion
31 Aug 2013
Completion
31 Dec 2013
Last update posted
25 Nov 2015
Registered enrollment
341
Registry id
NCT01612000

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.